Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

Longitudinal changes of blood parameters and weight in inoperable stage III NSCLC patients treated with concurrent chemoradiotherapy followed by maintenance treatment with durvalumab

Abstract Background Investigating dynamic changes in blood-parameters and weight in patients with locally advanced non-small cell lung cancer (NSCLC) receiving durvalumab maintenance therapy after chemoradiotherapy (cCRT). Laboratory outcomes were determined based on the number of durvalumab adminis...

Full description

Bibliographic Details
Main Authors: J. Guggenberger, S. Kenndoff, J. Taugner, L. Käsmann, B. Flörsch, C. Belka, C. Eze, F. Manapov
Format: Article
Language:English
Published: BMC 2022-03-01
Series:BMC Cancer
Subjects:
NSCLC
Durvalumab
Blood parameters
Prognostic factors
Dynamic changes
Online Access:https://doi.org/10.1186/s12885-022-09395-6

Internet

https://doi.org/10.1186/s12885-022-09395-6

Similar Items